Lawrence E. Bullock, Chief Financial Officer at BIOMIMETIC THERAPEUTICS, INC. (BMTI), bought 6,000 shares at $6.73 ($41K) on 2009-04-01, disclosed to the SEC on 2009-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.72 | 200 | $1K | 3.3% |
| 2 | $6.73 | 200 | $1K | 3.3% |
| 3 | $6.75 | 200 | $1K | 3.3% |
| 4 | $6.80 | 4,400 | $30K | 73.3% |
| 5 | $6.86 | 600 | $4K | 10.1% |
| 6 | $6.87 | 400 |
| $3K |
| 6.7% |
| Total | $6.80 avg | 6,000 | $41K | 100% |
| Filing → |
| BMTI | BUY | 2008-04-01 | $90K | — | Filing → |
| BMTI | BUY | 2006-05-15 | $80K | — | Filing → |